ALIVUS LIFE SCIENCES
Back to Balance Sheet
|
ALIVUS LIFE SCIENCES Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹470 Cr | ₹439 Cr | ₹1,015 Cr | ₹747 Cr | ₹1,445 Cr |
What is the latest Total Current Liabilities ratio of ALIVUS LIFE SCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹470 Cr |
| Mar2024 | ₹439 Cr |
| Mar2023 | ₹1,015 Cr |
| Mar2022 | ₹747 Cr |
| Mar2021 | ₹1,445 Cr |
How is Total Current Liabilities of ALIVUS LIFE SCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹470 Cr | 7.15 | |
| Mar2024 | ₹439 Cr | -56.77 | |
| Mar2023 | ₹1,015 Cr | 35.90 | |
| Mar2022 | ₹747 Cr | -48.32 | |
| Mar2021 | ₹1,445 Cr | - | |
Compare Total Current Liabilities of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹11,029.5 Cr | -0.1% | 3.3% | -10.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,121.0 Cr | 0.6% | -4.9% | -8.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,918.0 Cr | -1% | -1.7% | 5.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,960.0 Cr | 1.3% | 1.8% | 13.7% | Stock Analytics | |
| CIPLA | ₹122,725.0 Cr | 1.9% | -0.1% | -1.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,224.0 Cr | -1.4% | -2.2% | -8.3% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | -0.1% |
3.3% |
-10.2% |
| SENSEX | 0.9% |
0.4% |
9.3% |
You may also like the below Video Courses